SGS to operate Ph I inpatient clinical trials at Budapest hospital

By Melissa Fassbender contact

- Last updated on GMT

SGS to operate Ph I inpatient clinical trials at Budapest hospital

Related tags: Pharmacology, Hospital

SGS has signed a partnership agreement under which it will operate a dedicated clinical pharmacology unit for conducting Ph I inpatient clinical trials in Budapest, Hungary.

The agreement with the Medical Center of Defense Forces Hospital further expands the company’s embedded hospital clinical pharmacology network.

The clinical and bioanalytical contract solutions provider also has facilities in Antwerp and Mechelen, Belgium.

"Eastern ​Europe, and Hungary specifically, is a great place to reach naive patients and having this unit creates a win-win partnership between local experts and the hospital​," Florent Hediard at SGS Life Science told Outsourcing-Pharma.com.

"This ensures full control and oversight of clinical trials to guarantee the study trial quality, compliance with international rules, scientific exchanges between SGS and the hospital staff, and access for local patients to the latest treatments​."

As part of the agreement, the hospital dedicated some of its facilities and SGS invested in the equipment and local staff to maintain and manage the unit.

The new patient unit is located in a secured wing close to the intensive care unit and will feature five hospitalization beds. It is also equipped with an examination room, a sample preparation area, a sample storage area/locker, and restrooms.

A permanent, on-site SGS team will conduct the early phase trials in collaboration with hospital physicians, trial experts, and investigators.

"There is an ​on going clinical trial within this hospital for an oncology treatment​," Hediard explained. "SGS will use this new phase I unit to coordinate other 'sister' units within other hospitals with a local/close direct support​."

ISO 13485:2016

SGS has also announced​ that it has been granted accreditation for ISO 13485:2016, following a transition assessment done by United Kingdom Accreditation Service (UKAS).

According to the International Organization for Standardization (ISO), ISO 13485:2016 “specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements​.”

(Feature image: iStock/megaflopp)

Related topics: Clinical Development, Phase I-II

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Related suppliers

Follow us

Products

View more

Webinars